Sign up to save your podcasts
Or
Share Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the cerebral amyloid angiopathy as a risk factor for nontraumatic subdural hemorrhage, AI beats humans in neurology-like boards, and the impact of popular weight loss drugs on neurologic conditions.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the cerebral amyloid angiopathy as a risk factor for nontraumatic subdural hemorrhage, AI beats humans in neurology-like boards, and the impact of popular weight loss drugs on neurologic conditions.
More shows like Neurology Today in 5
View all
Neurology® Podcast
292 Listeners
NEJM This Week
313 Listeners
Practical Neurology Podcast
47 Listeners
This Week in Cardiology
864 Listeners
JAMA Clinical Reviews
494 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
90 Listeners
BMJ Best Practice Podcast
26 Listeners
The Clinical Problem Solvers
514 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Neurology Exam Prep Podcast
183 Listeners
The Curious Clinicians
364 Listeners
The Lancet Neurology in conversation with
5 Listeners
Continuum Audio
79 Listeners